A select group of S&P 500 companies are catching the eye of Wall Street, drawing in a wave of optimism with their impending quarterly reports. With around 20% of S&P 500 entities poised to unveil their figures next week, the spotlight falls on a diverse array of industries, from pharmaceutical giants like Eli Lilly and Vertex Pharmaceuticals to household names such as McDonald’s, Walt Disney, and the ride-hailing pioneer, Uber Technologies. The backdrop is intriguing: over 200 firms within the S&P 500 have already shared their fourth-quarter achievements, with approximately 74% surpassing the forecasts, although it’s noteworthy that this marks the lowest “beat” rate in a year, as pointed out by Societe Generale’s Manish Kabra.
The Screen for Success
In this dynamic landscape of companies set to report next week, filtering through those that have witnessed significant positive adjustments in earnings-per-share (EPS) estimates and price targets. The criteria are stringent, favoring firms with at least eight upward EPS revisions in the past three months, a minimum 5% increase in average EPS estimates over the same period, a 1% uptick in the past six months, and a 10% or more jump in average analyst price targets.
Allstate: The Insurance Maverick
Topping the list with nearly a 25% surge in price targets over three months, Allstate is gearing up for its earnings call on February 7. The insurer’s shares have enjoyed an 11.6% ascent since the year’s start, buoyed by a robust insurance market that’s benefiting from favorable premium pricing and easing inflationary pressures. Analysts see a potential 3% upside, with Morgan Stanley spotlighting Allstate as a standout in a thriving market environment, poised for enhanced earnings growth, especially in the personal auto segment.
Vertex Pharmaceuticals: The Biotech Beacon
Vertex Pharmaceuticals stands out with a 14% rise in EPS estimates following 21 upward revisions, showcasing strong analyst confidence ahead of its February 5 earnings announcement. The stock has already seen a 6.6% year-to-date increase, with a notable 36% climb over the past year. Goldman Sachs and JPMorgan are among the bullish voices, highlighting Vertex’s promising pipeline in pain management and cystic fibrosis treatments as key drivers for future revenue growth.
Uber Technologies: Navigating Success
Uber Technologies, set to report on February 7, has witnessed a remarkable 27 upward revisions in earnings estimates, coupled with a 17% hike in price targets over the past three months. Bank of America’s Justin Post points to Uber’s strong finish in 2023, improved profit margins, and aggressive cost-cutting measures as indicators of the company’s robust growth potential, positioning it as a leading growth story within the internet sector.
Gartner and Assurant: Under the Radar
Other notable mentions include Gartner and Assurant, both of which have shown strong earnings momentum leading into their respective earnings releases next week. These companies, though less highlighted, embody the diverse sectors and industries that are currently riding the wave of positive earnings revisions and heightened analyst expectations.
Looking Ahead
As the market anticipates these earnings releases, the overarching sentiment is one of cautious optimism. With a significant portion of the S&P 500 yet to report, the forthcoming week promises to bring clarity, potentially reshaping investor sentiments and market directions. Amidst this, the companies mentioned stand as beacons of potential, each with unique strengths and prospects that warrant close attention from investors and market watchers alike.
Stay up to date on other relevant news in our “Stock Market” section.
About Author
